In any peptide lab, the value of a test does not depend on the sample alone. It also depends on how that sample is kept from the day it is made to the day it is used. Poor care can lead to chain loss and poor test results. Like many other short-chain peptides, BPC-157 also […]
The post Laboratory Stability & Storage Protocols for BPC-157 appeared first on Medical News Bulletin.
Imagine undergoing endoscopy in the hopes of getting better medical direction, only to return home with a life-threatening bacterial infection. This sounds far-fetched, but this is the reality of many patients living in the United States. Reality of patients who went to the facilities that believed their equipment was clean and sanitized. Truth be told, […]
The post How Duodenoscope Infection Lawsuits Protect Future Patient Safety appeared first on Medical News Bulletin.
Veneers are everywhere these days from the smiles you see on reality TV to the before and after videos that fill up your social media feeds. This has got a lot of people asking questions. Mostly they all want to know one thing: what happens to the real tooth that is, under the veneer. People […]
The post Do Veneers Ruin the Teeth Underneath? Straight Answers to Common Veneer Questions appeared first on Medical News Bulletin.
Any one appointment can change the health outcome trajectory. Cervical cancer, heart disease and many other serious diseases develop without any apparent warning signs. Those routine visits also provide a way for a provider to detect those conditions early, before they become serious, so a routine visit is an important act of prevention. That’s why […]
The post How Regular Checkups Support Lifelong Women’s Health appeared first on Medical News Bulletin.
In a systematic review of the existing research into melatonin’s analgaesic potential, academics cautiously conclude that there is some evidence that melatonin helps with chronic muscular skeletal pain. Pain researchers from the University of Sydney, Australia, reported in an article for the medical journal Pain, that the sleep aid not only offers an upgrade in […]
The post Bulletin: Melatonin offers relief for chronic musculoskeletal pain appeared first on Medical News Bulletin.
Click here to read the Healio Exclusive, “Ophthalmic innovation: Growing a product from idea to market.”
A few years back, one of my surgical partners, Michael Greenwood, MD, and I had an idea for a product that would make things easier for our patients and us. That idea was to show patients what we mean when we discuss lens implants.
This was around the time when virtual reality headsets were becoming more common for personal use, and we both received them as gifts. We started talking about this idea of building out a software program that could communicate to patients what we know about the
PHOENIX — A single injection of sura-vec reduced the severity of nonproliferative diabetic retinopathy for up to 2 years, according to data presented at Optometry’s Meeting.
“Early intervention is essential to prevent progression to blinding complications, yet the burden of frequent intravitreal injections with current anti-VEGF therapies make long-term treatment difficult for many patients,” Steve Pakola, MD, chief medical officer at Regenxbio, told Healio. “We believe sura-vec has the potential to redefine the treatment paradigm by delivering sustained anti-VEGF expression through a
Cases of the Powassan virus — a rare but potentially fatal tickborne disease that can cause swelling of the brain — are on the rise nationwide.
The virus, for which there is no vaccine, hit an all-time high in 2025 with 76 U.S. cases, more than tripling the 24 cases from 4 years earlier, according to CDC data that date to 2004. From 2004-2025, the CDC has recorded 476 total cases, with 63 resulting in death.
Through June 30 of this year, the CDC has counted 15 cases of Powassan virus: eight in Massachusetts, three in Wisconsin, two in New York and one each in Pennsylvania and New
The FDA has approved a label expansion for Casgevy to include patients aged 2 years and older with sickle cell disease and transfusion-dependent beta thalassemia.
Previously approved for patients aged 12 years and older, Casgevy (exagamglogene autotemcel, Vertex Pharmaceuticals/CRISPR Therapeutics) is now the first and only gene therapy available for use in patients as young as 2 years with sickle cell disease with recurrent vaso-occlusive crises or transfusion-dependent beta thalassemia.
“These disorders carry a heavy burden for children and their families, affecting growth, development, and
The FDA declined to approve a biologics license application for Galderma’s relabotulinumtoxinA, citing manufacturing and testing concerns, according to a company press release.
In its complete response letter, the FDA stated that “observations during manufacturing site inspection and analytical method optimization” need to be addressed, according to the release. The agency did not mention any safety or efficacy concerns for relabotulinumtoxinA.
“The FDA made observations during the pre-license inspection for which Galderma is putting in place corrective and preventive actions,” the company said